TARGETING CD103+DENDRITIC CELLS USING FLT3 INHIBITORS FOR TREATMENT OF KIDNEY DISEASE; RELEVANCE TO HUMAN KIDNEY DISEASE

被引：0
|
作者：
Chen, T. [1 ,2 ,3 ]
Cao, Q. [1 ,2 ]
Wang, R. [1 ,2 ]
Rao, P. [1 ,2 ]
Zheng, G. [1 ,2 ]
Lee, V. [1 ,2 ,3 ]
Rogers, N. [1 ,2 ,3 ]
Patel, M. [1 ,2 ,3 ]
P'Ng, C. H. [1 ,2 ,3 ]
Yu, H. [2 ]
Alexander, S. [4 ]
Wang, Y. [1 ,2 ]
Harris, D. [1 ,2 ,3 ]
机构：
[1] Univ Sydney, Westmead, NSW, Australia
[2] Westmead Inst Med Res, Westmead, NSW, Australia
[3] Westmead Hosp, Westmead, NSW, Australia
[4] Childrens Hosp Westmead, Westmead, NSW, Australia
来源：
NEPHROLOGY | 2018年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：17 / 17
页数：1
相关论文
共 50 条
  • [1] Flt3 inhibition alleviates chronic kidney disease by suppressing CD103+ dendritic cell-mediated T cell activation
    Wang, Ruifeng
    Chen, Titi
    Wang, Chengshi
    Zhang, Zhiqiang
    Wang, Xin Maggie
    Li, Qing
    Lee, Vincent W. S.
    Wang, Yuan Min
    Zheng, Guoping
    Alexander, Stephen, I
    Wang, Yiping
    Harris, David C. H.
    Cao, Qi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 (11) : 1853 - 1863
  • [2] Aberrant migration of CD103+dendritic cells as a driver of disease in Alopecia areata
    Mattsson, J.
    Rehnberg, M.
    Krutrok, N.
    Astrand, A.
    Krishnaswamy, K.
    Jirholt, J.
    EXPERIMENTAL DERMATOLOGY, 2016, 25 : 46 - 46
  • [3] FLT3 inhibitors for the treatment of autoimmune disease
    Whartenby, Katharine A.
    Small, Donald
    Calabresi, Peter A.
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2008, 17 (11) : 1685 - 1692
  • [4] CD103+dendritic cells elicit CD8+T cell responses to accelerate kidney injury in Adriamycin nephropathy
    Cao, Q.
    Li, Q.
    Wang, X.
    Nguyen, H.
    Wang, C.
    Zheng, G.
    Wang, Y. M.
    Alexander, S. I.
    Wang, Y.
    Harris, D. C.
    NEPHROLOGY, 2015, 20 : 40 - 40
  • [5] FLT3/FLT3L-mediated CD103+ dendritic cells alleviates hepatic ischemia-reperfusion injury in mice via activation of treg cells
    Zhou, Chun-ze
    Wang, Rui-feng
    Cheng, De-lei
    Zhu, Yi-jiang
    Cao, Qi
    Lv, Wei-fu
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 118
  • [6] Flt3 ligand expands CD103+ dendritic cells and FoxP3+ T regulatory cells, and attenuates Crohn's-like murine ileitis
    Collins, Colm B.
    Aherne, Carol M.
    McNamee, Eoin N.
    Lebsack, Matthew D. P.
    Eltzschig, Holger
    Jedlicka, Paul
    Rivera-Nieves, Jesus
    GUT, 2012, 61 (08) : 1154 - 1162
  • [7] FLT3 Inhibitors for the Treatment of Acute Myeloid Leukemia: An Evaluation of Efficacy of Target Inhibition and Relationship to Disease Progression
    Cloe, Adam
    Larson, Richard A.
    Cheng, Jason X.
    BLOOD, 2015, 126 (23)
  • [8] Restoration Of Kidney Function In Chronic Kidney Disease (ckd) Using Autologous Human Renal Cells
    George, S. K.
    Huling, J.
    Abolbashari, M.
    Kim, T.
    Aboushwareb, T.
    Jackson, J. D.
    Atala, A.
    Yoo, J. J.
    TISSUE ENGINEERING PART A, 2022, 28 : 285 - 286
  • [9] RESTORATION OF KIDNEY FUNCTION IN CHRONIC KIDNEY DISEASE (CKD) USING AUTOLOGOUS HUMAN RENAL CELLS
    George, Sunil
    Huling, Jennifer
    Abolbashari, Mehran
    Kim, Tae Hyoung
    Aboushwareb, Tamer
    Jackson, John D.
    Atala, Anthony
    Yoo, James
    JOURNAL OF UROLOGY, 2024, 211 (05): : E1206 - E1206
  • [10] Small Molecule Inhibitors of MERTK and FLT3 Induce Cell Cycle Arrest in Human CD8+ T Cells
    Powell, Richard M.
    Peeters, Marlies J. W.
    Rahbech, Anne
    Aehnlich, Pia
    Seremet, Tina
    Straten, Per Thor
    VACCINES, 2021, 9 (11)
12345